OptimizeRx Corporation (OPRX)
| Market Cap | 1.38B |
| Revenue (ttm) | 51.80M |
| Net Income (ttm) | 788,995 |
| Shares Out | 17.62M |
| EPS (ttm) | 0.04 |
| PE Ratio | 1,860.00 |
| Forward PE | 82.64 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 132,142 |
| Open | 79.16 |
| Previous Close | 79.16 |
| Day's Range | 77.39 - 81.00 |
| 52-Week Range | 17.01 - 81.00 |
| Beta | 0.65 |
| Analysts | Strong Buy |
| Price Target | 73.33 (-6.1%) |
| Est. Earnings Date | Nov 9, 2021 |
About OPRX
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded mess...
Financial Performance
In 2020, OptimizeRx's revenue was $43.31 million, an increase of 76.08% compared to the previous year's $24.60 million. Losses were -$2.21 million, -29.77% less than in 2019.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for OptimizeRx stock is "Strong Buy." The 12-month stock price forecast is 73.33, which is a decrease of -6.13% from the latest price.
News
OptimizeRx and Demandbase Form Exclusive Account-Based-Experience (ABX) Partnership — Delivering Industry's Most Powe...
The Companies' combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction The Companies' combined point-of-care-engine creates an unmatched network of direct-t...
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 42.86% and 10.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx: Q2 Earnings Insights
Shares of OptimizeRx (NASDAQ:OPRX) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 400.00% year over year to $0.10, which beat the...
OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek I...
- Revenue Up 55% to $13.6 million, closing on 19 enterprise contracts- Enterprise deals pipeline grows from 46 to 63 - Brands adopting OptimizeRx solutions increases to 140 from 80 in the past 6 months-...
OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth
OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
ROCHESTER, Mich., July 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, w...
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement ...
OptimizeRx's AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans OptimizeRx's AI-driven platform leverages real-world evidence ...
2 Top Small-Cap Stocks to Buy in July
OptimizeRx and Nano-X Imaging are two of my favorite small-caps right now. Here's why.
OptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Here's Why
OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas
Continued focus on building and closing pipeline of enterprise solutions across oncology, cardiology and immunology Continued focus on building and closing pipeline of enterprise solutions across oncolo...
OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021
ROCHESTER, Mich., May 11, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, wi...
OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat Estimates
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 200.00% and 8.79%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health
ROCHESTER, Mich., May 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, re...
OptimizeRx Corp. (OPRX) Earnings Expected to Grow: Should You Buy?
OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptimizeRx Sets First Quarter 2021 Conference Call for Thursday, May 6, 2021 at 4:30 p.m. ET
ROCHESTER, Mich., April 28, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold ...
OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care
Several New Partnerships Expand Reach to Over 50% of Oncologists in the U.S. and Unlock Novel Touchpoints for Life Sciences to Engage Physicians Several New Partnerships Expand Reach to Over 50% of Onco...
OptimizeRx Named to Financial Times ―The Americas' Fastest-Growing Companies List for the Second Consecutive Year
Ranked #277, highlighting the growth potential and convergence between technology and healthcare Ranked #277, highlighting the growth potential and convergence between technology and healthcare
2 Biotech Stocks That Could Be Millionaire Makers
Why OptimizeRx and Ontrak might make you rich.
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
ROCHESTER, Mich., March 03, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited...
OptimizeRx Corp. (OPRX) Soars 12%: Is Further Upside Left in the Stock?
OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down ...
1 Under-the-Radar Stock For Healthcare Investors to Buy Now
OptimizeRx is disrupting the pharmaceutical sales call with an internet option for marketing drugs to doctors.
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Surpass Estimates
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 6.67% and 2.53%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per S...
ROCHESTER, Mich., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results ...
OptimizeRx's Angelo Campano Named to MM+M 40 Under 40 List
List Celebrates Accomplished Young Talent in Medical Marketing List Celebrates Accomplished Young Talent in Medical Marketing